Clinical trial
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
NCT05817604 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
- Lead sponsor
- Consorci Sanitari de Terrassa
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 1, 2023
- Completion date
- May 1, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inoperable disease, kidney neoplasm, renal cancer, sabr, sbrt